Saltar al contenido
Slide

An understanding of disease processes drives innovation in medicine

Slide

«A thinker sees his own actions as experiments
and questions, as attempts to find out something.
Success and failure are for him answers above all.»

Slide

«There is one thing even more vital to science than intelligent
methods; and that is the sincere desire to find out the truth,
whatever it may be.»

– Charles Pierce

Slide

«Every great advance in science has issued
from a new audacity of imagination»

– John Dewey

Slide

«Somewhere, something incredible is waiting to be known»

– Carl Sagan

Slide

«There is nothing which can better deserve your patronage
than the promotion of science and literature. Knowledge is in every country the surest basis of public happiness.»

– George Washington

Slide

«Learn from yesterday, live for today, hope for tomorrow
The important thing is to not stop questioning.»

– Albert Einstein

previous arrow
next arrow

Welcome

Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.

Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.

We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.

Follow us on Twitter to stay updated on news


New postdoctoral fellow

New postdoctoral fellow

Oct 25, 2017

Oct 2017 Thanks to Fundación Alfonso Martín Escudero, Samasta Gasco Cavero will join the MRC Harwell next January to generate humanised mouse models to investigate Cx43-related diseases. Leer más »New postdoctoral fellow

Science Xpression 2017 «Gap Junctions and Hemichannels: Physiological and Pathological Roles»

Science Xpression 2017 «Gap Junctions and Hemichannels: Physiological and Pathological Roles»

Oct 2, 2017

Sept 2017 Science Xpression Workshop Gap Junctions and Hemichannels: Physiological and Pathological Roles INIBIC, UDC, CICA, USC and Fundación Barrié Web: http://www.gapjunctionconference2017.com/Wellcome.html

Keynote Speaker at International Gap Junction Conference

Keynote Speaker at International Gap Junction Conference

Ago 3, 2017

Aug 2017    María D. Mayán will participate as keynote speaker at the International Gap Junction Conference organized by the European Gap Junction research community We are looking forward to enjoying the conference in…

Press and Disclosures

Press and Disclosures

Feb 24, 2017

February 2017 Micromecenazgo PRECIPITA Link La Voz de Galicia interview LINK

Press and Disclosures

Press and Disclosures

Feb 23, 2017

December 2016    Link International Young Investigator Meeting 2016 http://www.iyimeeting2016.com/Inicio.html        

New paper published in Biochimica et Biophysica Acta (BBA) – Molecular Cell Research

New paper published in Biochimica et Biophysica Acta (BBA) – Molecular Cell Research

Feb 21, 2017

Feb 2017    This research work was performed in collaboration with Eugenio Vazquez and José Luis Mascareñas from CIQUS and Anton Vila from UDC Biochimica et Biophysica Acta (BBA) – Molecular Cell Research…